Derham,
> I reckon the Jap deal will be a fizzer, ... and the $40m is on the never never.
On what basis do you make these claims?
> Personally I don't blame management for not completing as I just can't see why a company would do any significant deal pre human trials.
The reason is that there are researchers out there who are not just working with human tissue. Are you sure you have you done your research?
And by the way, it aint snowing in the Northern Hemisphere at the moment, it's Summer.
Cynata Therapeutics Ltd (ASX:CYP) Commentary on Industry News, page-36
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 19.0¢ | 18.0¢ | $328 | 1.791K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101249 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 118286 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |